Global Omega 3 Prescription Drugs Market By Drug Type (Vascepa, Lovaza, Omytrg and Others), By Indication (Severe Hypertriglyceridemia, Cardiovascular Risk Reduction, Cancer and Others), By Patient Type (Adult and Geriatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview The Global Omega 3 Prescription Drugs Market size is expected to be worth around US$ 3.0 Billion by 2034 from US$ 1.4 Billion in 2024, growing at a CAGR of 7.8% durin...